Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites
ClinicalTrials.gov study NCT05303844. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
ClinicalTrials.gov study NCT07395258. IPD Sharing: NO. Countries: 5. Publications: 0.
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lun
ClinicalTrials.gov study NCT07144280. IPD Sharing: YES. Countries: 11. Publications: 0.
Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients
ClinicalTrials.gov study NCT04555486. IPD Sharing: Not stated. Countries: 4. Publications: 0.
SCRT + mFOLFOX6 + PD-1 Antibody + Targeted Therapy for HIgh-Risk pMMR/MSS Rectal Cancer
ClinicalTrials.gov study NCT06908031. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time
ClinicalTrials.gov study NCT00809536. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer
ClinicalTrials.gov study NCT06787911. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.
ClinicalTrials.gov study NCT07234864. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
ClinicalTrials.gov study NCT04971499. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19
ClinicalTrials.gov study NCT04550325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NeuroGlove PD Study Clinical
ClinicalTrials.gov study NCT06578273. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Real World Study of Four PD-1 Agents in China
ClinicalTrials.gov study NCT03966456. IPD Sharing: NO. Countries: 1. Publications: 0.
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
ClinicalTrials.gov study NCT06253611. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma
ClinicalTrials.gov study NCT04038411. IPD Sharing: NO. Countries: 1. Publications: 0.
Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)
ClinicalTrials.gov study NCT07150949. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor
ClinicalTrials.gov study NCT04831320. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels
ClinicalTrials.gov study NCT05745727. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06161545. IPD Sharing: YES. Countries: 1. Publications: 0.
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
ClinicalTrials.gov study NCT06751901. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single-Arm, Phase Ⅰb Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC
ClinicalTrials.gov study NCT06690671. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.